Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001947094 | SCV002242467 | pathogenic | not provided | 2021-07-05 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg177Serfs*6) in the RIPK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RIPK1 are known to be pathogenic (PMID: 31213653). This variant has not been reported in the literature in individuals with RIPK1-related conditions. For these reasons, this variant has been classified as Pathogenic. |
3billion | RCV003152783 | SCV003841433 | pathogenic | Immunodeficiency 57 | 2023-02-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with RIPK1 related disorder (ClinVar ID: VCV001457300). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |